chr9-32480253-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014314.4(RIGI):​c.1740T>A​(p.Asp580Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,609,856 control chromosomes in the GnomAD database, including 14,151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D580N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.10 ( 999 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13152 hom. )

Consequence

RIGI
NM_014314.4 missense

Scores

6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.01

Publications

38 publications found
Variant links:
Genes affected
RIGI (HGNC:19102): (RNA sensor RIG-I) DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases which are implicated in a number of cellular processes involving RNA binding and alteration of RNA secondary structure. This gene encodes a protein containing RNA helicase-DEAD box protein motifs and a caspase recruitment domain (CARD). It is involved in viral double-stranded (ds) RNA recognition and the regulation of the antiviral innate immune response. Mutations in this gene are associated with Singleton-Merten syndrome 2. [provided by RefSeq, Aug 2020]
RIGI Gene-Disease associations (from GenCC):
  • Singleton-Merten syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Singleton-Merten dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015563965).
BP6
Variant 9-32480253-A-T is Benign according to our data. Variant chr9-32480253-A-T is described in ClinVar as Benign. ClinVar VariationId is 1168118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.143 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIGINM_014314.4 linkc.1740T>A p.Asp580Glu missense_variant Exon 12 of 18 ENST00000379883.3 NP_055129.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIGIENST00000379883.3 linkc.1740T>A p.Asp580Glu missense_variant Exon 12 of 18 1 NM_014314.4 ENSP00000369213.2
ENSG00000288684ENST00000681750.1 linkc.1590T>A p.Asp530Glu missense_variant Exon 14 of 20 ENSP00000506413.1

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15586
AN:
152134
Hom.:
1000
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0309
Gnomad AMI
AF:
0.178
Gnomad AMR
AF:
0.0878
Gnomad ASJ
AF:
0.207
Gnomad EAS
AF:
0.0133
Gnomad SAS
AF:
0.0629
Gnomad FIN
AF:
0.136
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.146
Gnomad OTH
AF:
0.123
GnomAD2 exomes
AF:
0.109
AC:
27302
AN:
251010
AF XY:
0.112
show subpopulations
Gnomad AFR exome
AF:
0.0255
Gnomad AMR exome
AF:
0.0585
Gnomad ASJ exome
AF:
0.207
Gnomad EAS exome
AF:
0.00881
Gnomad FIN exome
AF:
0.140
Gnomad NFE exome
AF:
0.149
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.129
AC:
187427
AN:
1457604
Hom.:
13152
Cov.:
31
AF XY:
0.128
AC XY:
92725
AN XY:
724696
show subpopulations
African (AFR)
AF:
0.0279
AC:
933
AN:
33460
American (AMR)
AF:
0.0634
AC:
2831
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
5425
AN:
26028
East Asian (EAS)
AF:
0.00974
AC:
386
AN:
39614
South Asian (SAS)
AF:
0.0668
AC:
5732
AN:
85850
European-Finnish (FIN)
AF:
0.138
AC:
7366
AN:
53304
Middle Eastern (MID)
AF:
0.216
AC:
1245
AN:
5752
European-Non Finnish (NFE)
AF:
0.141
AC:
155972
AN:
1108734
Other (OTH)
AF:
0.125
AC:
7537
AN:
60188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
8031
16061
24092
32122
40153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5366
10732
16098
21464
26830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15582
AN:
152252
Hom.:
999
Cov.:
32
AF XY:
0.100
AC XY:
7451
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0309
AC:
1282
AN:
41540
American (AMR)
AF:
0.0877
AC:
1341
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.207
AC:
718
AN:
3468
East Asian (EAS)
AF:
0.0133
AC:
69
AN:
5188
South Asian (SAS)
AF:
0.0628
AC:
303
AN:
4826
European-Finnish (FIN)
AF:
0.136
AC:
1444
AN:
10596
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.146
AC:
9918
AN:
68020
Other (OTH)
AF:
0.124
AC:
261
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
721
1442
2163
2884
3605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.123
Hom.:
475
Bravo
AF:
0.0964
TwinsUK
AF:
0.129
AC:
478
ALSPAC
AF:
0.142
AC:
549
ESP6500AA
AF:
0.0322
AC:
142
ESP6500EA
AF:
0.147
AC:
1268
ExAC
AF:
0.111
AC:
13445
Asia WGS
AF:
0.0760
AC:
264
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied by a panel of primary immunodeficiencies. Number of patients: 22. Only high quality variants are reported.

Singleton-Merten syndrome 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.024
T;T
Eigen
Uncertain
0.22
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.71
T;T
MetaRNN
Benign
0.0016
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;M
PhyloP100
2.0
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.8
N;N
REVEL
Benign
0.090
Sift
Benign
0.056
T;T
Sift4G
Uncertain
0.025
D;D
Vest4
0.092
ClinPred
0.030
T
GERP RS
4.7
Varity_R
0.26
gMVP
0.27
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17217280; hg19: chr9-32480251; COSMIC: COSV65881905; API